Report: Google to Settle With DOJ Over Illegal Pharma Ads

  |  May 13, 2011   |  Comments

Company has set aside $500 million for a possible DOJ settlement.

Google has set aside $500 million in anticipation of a settlement with the Department of Justice, the company revealed in its quarterly report to the Securities and Exchange Commission, filed Tuesday. According to a report by the Wall Street Journal, that settlement relates to Google's knowing acceptance of ads from online pharmacies that violate U.S. laws.

"In May 2011, in connection with a potential resolution of an investigation by the United States Department of Justice into the use of Google advertising by certain advertisers, we accrued $500 million for the three month period ended March 31, 2011," the SEC filing stated, adding, "Although we cannot predict the ultimate outcome of this matter, we believe it will not have a material adverse effect on our business."

Google declined to comment on the matter today, as did the Food and Drug Administration, which is reportedly working alongside the DOJ to investigate the company's practices. The DOJ had not returned requests for further information at the time of publish.

In 2003 Google said it would stop accepting ads from unlicensed pharmacies, and in 2007 the company, along with Microsoft and Yahoo, agreed to pay a combined $31.5 million fine in relation to the sale of ads for illegal gambling sites.

In September, Google attempted to deter the placement of illegal ads on its platform by filing a civil lawsuit in federal court against advertisers it believed deliberately broke its rules. In a blog post published at the time Michael Zwibelman, the company's Litigation Counsel, wrote, "As we and others build new safeguards and guidelines, rogue online pharmacies always try new tactics to get around those protections and illegally sell drugs on the web… This has meant that despite our best efforts - from extensive verification procedures, to automated keyword blocking, to changing our ads policies - a small percentage of pharma ads from these rogue companies is still appearing on Google."

According to the WSJ report, however, the DOJ is currently trying to establish whether or not Google executives were in fact aware of the illegal ads it was selling, and turned a blind eye to that activity.

Tags:

ClickZ Live Chicago Learn Digital Marketing Insights From Leading Brands!
ClickZ Live Chicago (Nov 3-6) will deliver over 50 sessions across 4 days and 10 individual tracks, including Data-Driven Marketing, Social, Mobile, Display, Search and Email. Check out the full agenda, or register and attend one of the best ClickZ events yet!

ABOUT THE AUTHOR

Jack Marshall

Jack Marshall was a staff writer and stats editor for ClickZ News from 2007 until August 2011. 

COMMENTSCommenting policy

comments powered by Disqus

Get the ClickZ Search newsletter delivered to you. Subscribe today!

COMMENTS

UPCOMING EVENTS

UPCOMING TRAINING

Featured White Papers

Google My Business Listings Demystified

Google My Business Listings Demystified
To help brands control how they appear online, Google has developed a new offering: Google My Business Locations. This whitepaper helps marketers understand how to use this powerful new tool.

5 Ways to Personalize Beyond the Subject Line

5 Ways to Personalize Beyond the Subject Line
82 percent of shoppers say they would buy more items from a brand if the emails they sent were more personalized. This white paper offer five tactics that will personalize your email beyond the subject line and drive real business growth.

WEBINARS

Resources

Jobs